Evelo Biosciences is a startup based in the United States, 2 tracked investors.
Evelo Biosciences is a startup founded in 2015 based in the United States. Brouky records 2 investors associated with the company.
Evelo Biosciences develops oral biologic drugs based on the human microbiome to treat inflammation, cancer, and other immune-mediated diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.